Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
13Dec2025
  • Home
  • About
  • News
  • Subscribe
13Dec2025
Cost Curve NewsCost Curve News
Cost Curve News

A New Lawsuit Crystallizes the Abuses and Lack of Oversight in 340B

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
12 months ago
Keep Reading
Cost Curve News

CMS’ Explanations for ‘Maximum Fair Prices’ Feel a Bit Like Coal in the Stocking

On Friday, I was cagey about whether there would be a Christmas-week newsletter. I was worried that some resident of Mount Crumpit would be tempted to throw something important into
12 months ago
Keep Reading
Cost Curve News

Pre-Holiday Wrap: A Couple New Drugs, Some Health Policy Chatter, and More Analyses Putting MFPs in Context

In theory, this is my last newsletter for the next 10 days. I say “in theory,” because I figure there’s a 50/50 chance of someone dumping news into the void
12 months ago
Keep Reading
Cost Curve News

American Health Care : The Best (?) System that $4.9 Trillion Can Buy

Quick Brian Reid Scheduling Note: I’ve only missed a couple of J.P. Morgan Healthcare Conferences since 2010 (with the exception of the pandemic years, which we don’t talk about).  But
12 months ago
Keep Reading
Cost Curve News

A Section-by-Section Breakdown of the PBM Provisions in the Big Year-End Spending Bill

Thanks to everyone who weighed in on the future of Cost Curve yesterday. I’m keeping the survey open for another day, so if you haven’t clicked over, I’d be appreciative
12 months ago
Keep Reading
Cost Curve News

Today Is the Biggest Day Ever for PBM News, No?

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
12 months ago
Keep Reading
Cost Curve News

J&J Expands Its Legal Attack on ‘Alternative Funding Programs’ to Include a PBM

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
12 months ago
Keep Reading
Cost Curve News

ICER’s ‘Unsupported Price Increases’ Report Misses the Mark. Again.

Programming Note: No Curve tomorrow unless there’s news [knocks on wood]. Back Monday. Let it snow. If you want to search Cost Curve back issues or link to anything you
1 year ago
Keep Reading
Cost Curve News

Pictures Are Worth a Thousand Words … So Here Are 3,000 Words on IRA, UM, and Formulary Design

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
1 year ago
Keep Reading
Cost Curve News

A Clip-n-Save Guide to the Next 15 Medicines Up for Medicare Price Controls

I really tried to make it a whole newsletter without mentioning 340B. I came close, but — alas — I can’t get away. If you want to search Cost Curve
1 year ago
Keep Reading
232425

Latest Posts

A New Tracker for Watching Meds That Might See Prices Slashed

December 10, 2025

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

December 9, 2025

Reimbursement for Hep B Shots Should Remain Stable Even as CDC Panel Undermines the Vaccine

December 8, 2025

A New Health Affairs Forefront Piece Seeks to Reset the ‘Pharm-to-Table’ Conversation

December 5, 2025

Companies and Nations Respond to the U.S.-U.K. Agreement to Eliminate Tariffs, Boost Drug Prices

December 4, 2025

Popular

A New Tracker for Watching Meds That Might See Prices Slashed

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

Reimbursement for Hep B Shots Should Remain Stable Even as CDC Panel Undermines the Vaccine

A New Health Affairs Forefront Piece Seeks to Reset the ‘Pharm-to-Table’ Conversation

Companies and Nations Respond to the U.S.-U.K. Agreement to Eliminate Tariffs, Boost Drug Prices

The Need-to-Know on a Slow News Day: More MFN Deals Are Coming, and Why Pharma Thinks the U.S./U.K. Trade Agreement Should Be a Model

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,939)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (2,029)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,921)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,717)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,709)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

A New Tracker for Watching Meds That Might See Prices Slashed

December 10, 2025

Why IRA ‘Negotiations’ and MFN Dealmaking Led to Such Different Prices for Ozempic and Wegovy

December 9, 2025

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2025 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe